REGENERON PHARMACEUTICALS COM is a security (CUSIP 75886F107) tracked across SEC portfolio filings. 1,415 institutional managers reported $66.1B on Form 13F as of 2026-06-30; 125 registered fund positions totaling $7.1B via N-PORT as of 2026-06-30.
Showing 15 of 1,415 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| VANGUARD GROUP INC | Valley Forge, PA | $7.0B | 9,075,153 |
| BlackRock, Inc. | New York, NY | $6.9B | 8,947,735 |
| STATE STREET CORP | BOSTON, MA | $3.6B | 4,664,478 |
| Dodge & Cox | San Francisco, CA | $3.4B | 4,458,238 |
| JPMORGAN CHASE & CO | NEW YORK, NY | $3.2B | 4,311,806 |
| FRANKLIN RESOURCES INC | San Mateo, CA | $2.1B | 2,722,071 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $2.0B | 2,607,732 |
| Invesco Ltd. | ATLANTA, GA | $1.7B | 2,180,631 |
| Nuveen, LLC | CHARLOTTE, NC | $1.6B | 2,065,064 |
| LOOMIS SAYLES & CO L P | BOSTON, MA | $1.5B | 1,912,310 |
| WELLINGTON MANAGEMENT GROUP LLP | BOSTON, MA | $1.4B | 1,837,459 |
| FMR LLC | BOSTON, MA | $1.2B | 1,518,192 |
| GOLDMAN SACHS GROUP INC | NEW YORK, NY | $1.2B | 1,300,558 |
| Capital World Investors | LOS ANGELES, CA | $1.1B | 1,419,000 |
| MORGAN STANLEY | NEW YORK, NY | $1.0B | 1,319,329 |
Showing 15 of 125 fund positions by value.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| Invesco QQQ Trust, Series 1 | Invesco QQQ Trust, Series 1 | $1.7B | 45.40% |
| State Street(R) SPDR(R) S&P 500(R) ETF Trust | State Street(R) SPDR(R) S&P 500(R) ETF Trust | $910.1M | 13.97% |
| Putnam Large Cap Value Fund | Putnam Large Cap Value Fund | $807.9M | 160.91% |
| VANGUARD HEALTH CARE FUND | VANGUARD SPECIALIZED FUNDS | $658.9M | 178.75% |
| Dodge & Cox Global Stock Fund | Dodge & Cox Funds | $435.1M | 362.39% |
| New Perspective Fund | New Perspective Fund | $361.3M | 23.65% |
| Pioneer Fund | PIONEER FUND /MA/ | $302.2M | 336.93% |
| Fidelity Contrafund | Fidelity Contrafund | $291.9M | 18.50% |
| T. Rowe Price Health Sciences Fund, Inc. | T. ROWE PRICE HEALTH SCIENCES FUND, INC. | $288.4M | 264.72% |
| T. Rowe Price U.S. Large-Cap Core Fund, Inc. | T. ROWE PRICE U.S. LARGE-CAP CORE FUND, INC. | $159.4M | 96.52% |
| Invesco S&P 500 Equal Weight ETF | Invesco Exchange-Traded Fund Trust | $154.0M | 17.53% |
| Growth Fund of America | Growth Fund of America | $115.0M | 3.19% |
| AB Relative Value Portfolio | AB VARIABLE PRODUCTS SERIES FUND, INC. | $75.4M | 724.31% |
| SOUND SHORE FUND | SOUND SHORE FUND, INC. | $68.1M | 739.43% |
| Capital Group Global Growth Equity ETF | Capital Group Global Growth Equity ETF | $64.7M | 57.28% |